Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s bispecific antibody targeting PD-L1 and VEGF-A, BNT-327, in a deal possibly worth over $11 billion. The companies will ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

As China strides confidently toward its goal of becoming a global innovation powerhouse, French pharmaceutical company Ipsen, ...

More hijinx from the Herald ...

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 ...

First-in-class antibody-drug conjugate, pivekimab sunirine (PVEK), was safe and effective. PVEK achieved an overall response rate of 85% and complete response rate of 70% as frontline treatment in ...

🌌 Jupiter - French Verb Conjugator 🇫🇷 Jupiter is a desktop application built using Python and Kivy that allows users to conjugate French verbs across 9 different tenses using a simple and clean ...

The high disease incidence recorded in four countries, the high prevalence of typhoid hospitalisations and complicated disease, and the threat of multidrug resistant S Typhi strains call for the ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252080; ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.